Point-of-care musculoskeletal ultrasound for hemophilic arthropathy: a scoping review of scanning protocols by the Imaging Expert Working Group of the International Prophylaxis Study Group
Several POC-MSKUS scanning protocols exist, with predictive validity and responsiveness being the least established measurement properties. Future research should focus on prospective and experimental studies to establish these properties in POC-MSKUS protocols for PwH and people with VWD.
Authors
- Paul Babyn (ORCID: https://orcid.org/0000-0001-8965-7305)
- Annette von Drygalski (ORCID: https://orcid.org/0000-0002-9426-6322)
- Karen Strike (ORCID: https://orcid.org/0000-0002-5598-2051)
- Björn Lundin (ORCID: https://orcid.org/0000-0001-9643-2921)
- Amy L. Dunn (ORCID: https://orcid.org/0000-0002-9645-6365)
- Nihal Bakeer (ORCID: https://orcid.org/0000-0002-3370-8166)
- Helen Pergantou (ORCID: https://orcid.org/0000-0002-1792-0597)
- Khang Nguyen (ORCID: https://orcid.org/0000-0003-1366-7456)
Institutions
- Nationwide Children's Hospital (US)
- Children's Hospital of Philadelphia (US)
- University of San Diego (US)
- Lund University (SE)
- Saskatchewan Health Authority (CA)
- McMaster Children's Hospital (CA)
- University of California San Diego (US)
- Saskatoon Medical Imaging (CA)
- Children's Hospital Agia Sophia (GR)
- Skåne University Hospital (SE)
- Indiana Hemophilia and Thrombosis Center (US)
- Hamilton Health Sciences (CA)
- University of Pennsylvania (US)
- McMaster University (CA)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.rpth.2025.103185
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- BioMarin Pharmaceutical
- Novo Nordisk
- Hospital for Sick Children
- Swedish Orphan Biovitrum
- Bayer Canada